Physician

Paul Mazzeo, M.D.

According to 2025 Medicare claims, Paul Mazzeo, M.D. (NPI: 1568432185) practices neurology in the Hilton Head Island-Bluffton-Port Royal, SC market, with the plurality of this provider's patient population coming from Beaufort, SC. This provider's primary affiliated billing organization is COASTAL NEUROLOGY, P.A. (NPI: 1750346789; TIN: 571021811) and primary practice location at 29935-2029.

Mazzeo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,124 traditional Medicare patients, billed 752,533 HCPCS/CPT codes, and received $1,543,169 in Medicare payments. The top billing code was 99483 (Assessment of and care planning for patient with impaired thought processing, typically 60 minutes). Part D data shows 1,721 prescription claims across 372 beneficiaries totaling $442,759 in drug costs, led by Gamunex-C (Immune Globul G/Gly/Iga Avg 46). 2018 DME data shows 16 claims. Open Payments data shows 141 records totaling $199,215. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $373,487 to $1,543,169. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	996	18,607	$373,487
2016	982	17,385	$369,328
2017	1,085	15,977	$411,315
2018	1,144	18,735	$432,394
2019	1,120	20,643	$437,102
2020	1,031	18,723	$408,095
2021	1,222	24,878	$532,809
2022	1,187	29,850	$661,322
2023	1,229	94,849	$878,960
2024	1,124	752,533	$1,543,169

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	250	1,675	$358,679
2016	259	1,711	$469,768
2017	271	1,731	$449,658
2018	297	1,809	$390,924
2019	326	1,783	$373,803
2020	323	1,676	$359,551
2021	320	1,615	$322,054
2022	363	1,503	$335,144
2023	384	1,700	$576,444
2024	372	1,721	$442,759

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	16	$613
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99483	Assessment of and care planning for patient with impaired thought processing, typically 60 minutes	329	391	$199
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	312	312	$152
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	483	757	$132
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	141	191	$94
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	117	123	$68

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	12	476	$64,612
Botox	Onabotulinumtoxina	19	1,602	$24,246
Emgality Pen	Galcanezumab-Gnlm	14	540	$12,495
Memantine Hcl	Memantine Hcl	210	15,644	$8,625
Rivastigmine	Rivastigmine	24	1,320	$4,614

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	128	$11,295	Eisai Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	13	$187,920	Eisai Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Paul Mazzeo, M.D.?

Tedicare shows public-source Medicare data for Paul Mazzeo, M.D. (NPI 1568432185), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paul Mazzeo, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Paul Mazzeo, M.D.?

Paul Mazzeo, M.D. is linked to COASTAL NEUROLOGY, P.A. (billing NPI 1750346789) in the available physician profile data.

Does Paul Mazzeo, M.D. have Open Payments data?

Paul Mazzeo, M.D. has 141 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.